Indeed, CD8+ T cells are most likely functionally relevant in NSCLC, as the number of apoptotic tumor cells was significantly higher in tumors with a high number of CD3+ and CD8+ T cells [15] therefore CD8+ T lymphocytes comprise a well-established group of effector T cells with potent cytotoxic effects in cancer [16]. The gene discussed is CD8A; the disease is neoplasm.